1 completed, 1 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Carcinoma of Larynx: new trials by email Literature Review of Carcinoma of Larynx trials Research Report on Carcinoma of Larynx
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer SX-682, DTX - Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma | Phase 1 / Phase 2 | Recruiting | National Cancer Institute (NCI) | 120 | 2026-11-11 | 2026-11-06 |
| Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck BKM120, Cisplatin, Intensity-modulated radiotherapy (IMRT) - Carcinoma, Squamous Cell of Head and Neck, HPV Positive Oropharyngeal Squamous Cell Carcinoma | Phase 1 | Completed | Dana-Farber Cancer Institute | 23 | 2014-09-29 | 2026-11-05 |
Hypopharyngeal Neoplasms (2) · Laryngeal Neoplasms (2) · Squamous Cell Carcinoma of Head and Neck (2) · Carcinoma (1) · Carcinoma, Adenoid Cystic (1) · Head and Neck Neoplasms (1) · Nasopharyngeal Carcinoma (1) · Nasopharyngeal Neoplasms (1) · Paranasal Sinus Neoplasms (1) · Prostatic Neoplasms (1) · Salivary Gland Neoplasms (1)
Carcinoma, Squamous Cell (2) · Laryngeal Diseases (2) · Nasopharyngeal Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Otorhinolaryngologic Diseases (2) · Otorhinolaryngologic Neoplasms (2) · Pharyngeal Diseases (2) · Pharyngeal Neoplasms (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2) · Stomatognathic Diseases (2) · Adenocarcinoma (1)
Cisplatin (1) · NVP-BKM120 (1) · Radiotherapy, Intensity-Modulated (1)
Dana-Farber Cancer Institute (1) · National Cancer Institute (NCI) (1)
United States (2)
Charalampos Floudas, M.D. (1) · Robert Haddad, MD (1)